CORTISONE ACETATE (cortisone acetate) by Pfizer is clinical pharmacology: naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Approved for prostate cancer, atopic dermatitis, chronic kidney disease and 1 more indications. First approved in 1951.
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
Cortisone acetate is a naturally occurring glucocorticoid used for replacement therapy in adrenocortical deficiency and as a potent anti-inflammatory agent across multiple organ systems. It modifies immune responses and produces profound metabolic effects, making it a foundational corticosteroid therapy. The oral tablet formulation has been a clinical staple since 1951.
As a legacy product approaching LOE with minimal competitive pressure (30%), the brand team is likely focused on cost optimization and portfolio integration rather than growth initiatives.
CLINICAL PHARMACOLOGY: Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders of many organ…
Worked on CORTISONE ACETATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on cortisone acetate offers limited growth trajectory but provides stability and deep domain expertise in corticosteroid therapeutics and chronic disease management. Roles are predominantly in field execution, market access optimization, and physician education rather than high-visibility innovation or launch activities.